| scholarly article | Q13442814 |
| P2093 | author name string | Bin Xiong | |
| Yun-Feng Zhou | |||
| Wei-Dong Hu | |||
| Min Mao | |||
| Fu-Lin Cheng | |||
| Tao-Jiao Sun | |||
| P2860 | cites work | Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis | Q43913613 |
| Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines | Q43945231 | ||
| Prostaglandin E2 down-regulates viable Bacille Calmette-Guérin-induced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro | Q43975333 | ||
| Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. | Q44061952 | ||
| Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. | Q44068607 | ||
| Cyclooxygenase-2 expression in colorectal cancer liver metastases. | Q52863062 | ||
| Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. | Q53413758 | ||
| Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. | Q54042218 | ||
| Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer | Q73404061 | ||
| Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors | Q73574321 | ||
| Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines | Q73803470 | ||
| Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells | Q74127393 | ||
| Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer | Q77476553 | ||
| Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells | Q24681236 | ||
| COX-2 expression and cell cycle progression in human fibroblasts | Q28184985 | ||
| Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44 | Q28363575 | ||
| A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2. | Q31983653 | ||
| Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis | Q33180353 | ||
| Cyclooxygenase-2: a novel target for cancer chemotherapy? | Q34317347 | ||
| Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 | ||
| Celecoxib: a specific COX-2 inhibitor with anticancer properties | Q34608635 | ||
| Host cyclooxygenase-2 modulates carcinoma growth. | Q40365112 | ||
| Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. | Q40737945 | ||
| von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis | Q40759870 | ||
| Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis | Q40789590 | ||
| Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. | Q40806517 | ||
| Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma | Q41774814 | ||
| Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases | Q42797828 | ||
| Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. | Q43557993 | ||
| In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detection using bovine aortic coronary endothelial cells (BAECs). | Q43642624 | ||
| Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells | Q43726282 | ||
| Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. | Q43865490 | ||
| Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo | Q43878441 | ||
| Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions | Q43891702 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 1105-1108 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance | |
| P478 | volume | 11 |
| Q58773124 | -Catenin Regulation in Sporadic Colorectal Carcinogenesis: Not as Simple as APC |
| Q42935094 | Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma. |
| Q96136776 | Avenanthramide C suppresses hypoxia-induced cyclooxygenase-2 expression through sirtuin1 activation in non-small-cell lung cancer cells |
| Q51773839 | Comparison of cyclooxygenase-2 and CD44 mRNA expression in colorectal cancer and its relevance for prognosis. |
| Q35904309 | Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma |
| Q83682572 | Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats |
| Q53314572 | Expression of COX-2 in stomach carcinogenesis. |
| Q37065420 | Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers |
| Q36971223 | Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer |
| Q39704974 | Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells |
| Q93059354 | Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients |
| Q43879599 | Over-expression of cyclooxygenase-2 in endoscopic biopsies of ectopic gastric mucosa |
| Q34666351 | Prognostic importance of increased cyclooxygenase-2 levels in colorectal carcinomas: a 5-year single-institution study |
Search more.